Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
MacroGenics Inc.

Start price
Target price
Perf. (%)
€12.17
13.01.22
-
13.01.23
-7.52%
22.01.22

Could be worthwhile Investment >10% per year
Vassago1 
13.01.22 50%
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€16.62
14.01.22
-
14.01.23
-12.67%
22.01.22

Could be worthwhile Investment >10% per year
Vassago1 
14.01.22 50%
buy
Axsome Therapeutics Inc

Start price
Target price
Perf. (%)
€24.44
14.01.22
-
14.01.23
-10.19%
22.01.22

Risky Investment
Vassago1 
14.01.22 50%
buy
Dare Bioscience Inc.

Start price
Target price
Perf. (%)
€2.50
21.01.21
€10.00
21.01.22
-47.52%
22.01.22

Could be very worthwhile Investment >20% year
Maxi_Scalibusa 
21.01.21 50%
buy
Lipocine Inc.

Start price
Target price
Perf. (%)
€32.30
21.01.21
€136.00
21.01.22
-57.58%
22.01.22

Could be very worthwhile Investment >20% year
Maxi_Scalibusa 
21.01.21 50%
buy
Bayer AG

Start price
Target price
Perf. (%)
€49.60
10.01.22
€70.00
10.01.23
3.36%
22.01.22

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
gerihouse 
10.01.22 80%
buy
Bayer AG

Start price
Target price
Perf. (%)
€49.60
10.01.22
€70.00
10.01.23
3.36%
22.01.22

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
gerihouse 
10.01.22 80%
buy
Magenta Therapeutics

Start price
Target price
Perf. (%)
€4.08
08.01.22
€6.00
08.01.23
-26.40%
22.01.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
nvestor 
08.01.22 50%
buy
Immuron

Start price
Target price
Perf. (%)
€2.10
08.01.22
€4.00
08.01.23
39.05%
22.01.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
nvestor 
08.01.22 50%
buy
Zoetis Inc. A

Start price
Target price
Perf. (%)
€130.34
27.02.21
-
27.02.22
37.81%
20.01.22

Innovative
Medium risks for its business
Top 10 in its market
Future proof or reliable business model
Troubadour 
27.02.21 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€55.31
19.01.21
€67.00
19.01.22
14.53%
20.01.22

Top 10 in its market
Good rating
Medium risks for its business
Bad culture
Snowman 
19.01.21 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€55.31
19.01.21
€67.00
19.01.22
14.53%
20.01.22

Top 10 in its market
Good rating
Medium risks for its business
Bad culture
Snowman 
19.01.21 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€55.31
19.01.21
€67.00
19.01.22
14.53%
20.01.22

Top 10 in its market
Good rating
Medium risks for its business
Bad culture
Snowman 
19.01.21 50%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€41.11
09.11.21
€60.00
09.11.22
14.73%
19.01.22

Small challenges to pay loans and raise capital
Innovative
Very small cyclical dependencies
Some uniques
Snowman 
09.11.21 70%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€41.11
09.11.21
€60.00
09.11.22
14.73%
19.01.22

Small challenges to pay loans and raise capital
Innovative
Very small cyclical dependencies
Some uniques
Snowman 
09.11.21 70%
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€173.98
25.01.21
€250.00
25.01.22
23.00%
17.01.22

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
gerihouse 
25.01.21 90%
sell
DBV Technologies S.A.

Start price
Target price
Perf. (%)
€8.16
15.01.21
-
15.01.22
-63.58%
16.01.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
shadow 
15.01.21 0%
buy
Biogen Inc.

Start price
Target price
Perf. (%)
€194.22
12.01.22
€240.00
12.01.23
-0.90%
12.01.22

Could be worthwhile Investment >10% per year
Known brand
phonebroker 
12.01.22 50%
buy
Biogen Inc.

Start price
Target price
Perf. (%)
€194.22
12.01.22
€240.00
12.01.23
-0.90%
12.01.22

Could be worthwhile Investment >10% per year
Known brand
phonebroker 
12.01.22 50%
buy
Biogen Inc.

Start price
Target price
Perf. (%)
€194.22
12.01.22
€240.00
12.01.23
-0.90%
12.01.22

Could be worthwhile Investment >10% per year
Known brand
phonebroker 
12.01.22 50%
buy
Jazz Pharmaceuticals plc

Start price
Target price
Perf. (%)
€130.15
12.01.22
-
12.01.23
0.00%
12.01.22

Joe130978 
12.01.22 50%
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€183.96
17.12.21
€240.00
17.12.22
-37.46%
10.01.22

Could be worthwhile Investment >10% per year
Some uniques
Sievi 
17.12.21 50%
buy
Genocea Biosciences Inc.

Start price
Target price
Perf. (%)
€1.15
27.12.21
-
27.12.22
-18.26%
10.01.22

Could be worthwhile Investment >10% per year
Sievi 
27.12.21 0%
buy
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€18.94
05.01.22
-
05.01.23
-7.08%
09.01.22

Risky Investment
Global_Player 
05.01.22 50%
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€143.65
27.12.21
-
27.12.22
-9.78%
09.01.22

Risky Investment
Vassago1 
27.12.21 50%